Medical Devices News and Research

RSS

Roundup: Ariz. examines complaints of prisoners' medical health care; Calif. settles suit on kids' mental health services

To stave off a lawsuit, Arizona's Department of Corrections has agreed to investigate scores of complaints by inmates that they are routinely denied medical care for weeks or months even for severe, life-threatening conditions. Inmates who have lost sight, had body parts amputated or been severely disfigured, among other gruesome examples, say proper medical care could have prevented needless suffering.

6 Dec 2011

Medicare tightening payments for 'big ticket' cardiology and orthopedic procedures in 11 states

In an effort to rein in costs, the Centers for Medicare and Medicaid Services will in 2012 perform an audit before paying for certain cardiology and orthopedic procedures in key states, including Florida.

6 Dec 2011

Enrollment commences in Estech's HISTORIC-AF staged hybrid ablation study

Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORIC-AF European multi-center staged hybrid ablation clinical study.

5 Dec 2011

Herzig Eye Institute named TearScience's first Center of Excellence

TearScience, Inc., a privately-held medical device company, today announced Toronto-based Herzig Eye Institute, one of the leading authorities in laser vision correction and advanced cataract and refractive surgery, as its first Center of Excellence.

5 Dec 2011

InfraReDx receives $10M senior secured multi-draw term loan from GE Capital

GE Capital, Healthcare Financial Services announced today that it was the sole lender on a $10 million senior secured multi-draw term loan to InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases. The financing will be used to help support product commercialization efforts.

5 Dec 2011

University of Illinois Hospital prescribes Tumor Treating Fields therapy for recurrent GBM

The University of Illinois Hospital is the first center in North America to prescribe a new FDA-approved treatment for patients with the most common and aggressive type of brain tumor, glioblastoma multiforme, or GBM.

3 Dec 2011

FDA issues draft guidance on artificial pancreas system

The U.S. Food and Drug Administration today issued draft guidance designed to help investigators and manufacturers as they develop and seek approval for artificial pancreas device systems to treat type 1 diabetes.

2 Dec 2011

Enhanced services and higher quality benefits lead to improved health

Community health plans are partnering with physician practices to initiate a range of care management programs for people living with chronic diseases; these programs have resulted in decreased emergency room (ER) use, improved health and lower costs. The findings, released today by the Alliance of Community Health Plans (ACHP), are part of a report that is a comprehensive look at the way community health plans partner with providers to improve care.

1 Dec 2011

New issue of Index on Censorship magazine calls for debate into science and transparency

As thousands more emails from the University of East Anglia's Climatic Research Unit (CRU) are leaked on the internet, the latest issue of Index on Censorship magazine, 'Dark Matter', calls for a debate into science and transparency.

1 Dec 2011

USPTO issues Notice of Allowance to Emboline's aortic devices for TAVR procedures

Emboline, Inc., an emerging medical device company, has received Notice of Allowance from the United States Patent and Trademark Office (USPTO) related to its aortic embolic protection devices for percutaneous heart valve repair and replacement.

1 Dec 2011

UL researchers to develop a medical device to improve detection of delirium

Researchers at the Graduate Entry Medical School, University of Limerick (GEMS) have been awarded €175,000 funding to develop a portable automated device that can be used in any clinical or community setting to allow early diagnosis and treatment of delirium.

30 Nov 2011

BioLineRx reports third quarter net loss of NIS 7.9 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the third quarter ending September 30, 2011.

29 Nov 2011

Mindray to introduce new DC-T6 ultrasound system at RSNA 2011

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will introduce the new DC-T6 ultrasound system at the annual Radiological Society of North America conference.

From Mindray 28 Nov 2011

Bacterin to distribute Jeil's LeForte craniomaxillofacial system in the U.S. and Canada

Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and antimicrobial coatings for medical applications, signed an exclusive agreement with Jeil Medical Corporation for distribution in the U.S. and Canada of Jeil's LeForte System.

28 Nov 2011

TRIGOcare, Systagenix partner to deliver wound care products

In a pressed economic climate, the estimated 3 million chronic wounds treated every year costs the German health care system several billion Euros, a situation fuelled by an annual prevalence of 650,000 new patients. This creates an immense cost pressure on everyone involved in wound care, in a market already characterised by tough competition, ever changing political framework and an expectation of innovation and improved quality of care.

22 Nov 2011

FDA allows marketing of Aptus EndoStapling System to treat AAA

The U.S. Food and Drug Administration today allowed marketing of the first system that can repair a failed or problematic aortic endograft, a fabric tube used to repair a dangerously large aortic aneurysm, a bulge in the large blood vessel that carries blood away from the heart.

22 Nov 2011

FDA clears Aptus EndoStapling System to treat AAA

Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Aptus EndoStapling System, which will now be known as the HeliFX™ Aortic Securement System.

21 Nov 2011

Covidien to acquire BÂRRX Medical

Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.

21 Nov 2011

Medizone, SMTC enter partnership to manufacture AsepticSure disinfection system

Medizone International, a leading-edge research and development company that specializes in decontamination and sterilization systems and SMTC Corporation, a global electronics manufacturing services provider, today jointly announce a new partnership agreement to manufacture Medizone's AsepticSure disinfection system.

21 Nov 2011

ICON selected as CRO for Tasly's Dantonic pill global Phase III studies for chronic stable angina pectoris

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been selected by Tasly Pharmaceuticals for the company's global Phase III T89 trial. T89, also known as Dantonic pill, aims to become the first traditional Chinese medicine to receive FDA approval in the United States.

21 Nov 2011